Should I buy Marsh McLennan (MRSH) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 72% of its targets hit on this sector (18 calls tested). It aims for $218 (+15 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
✅ Reasons to believe
- Pays a dividend (2.1% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 12 ratings, 6 are neutral and 1 is a sell.
- Limited upside: the median target is only +6% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on MRSH
Median target $202 (+6%) · 12 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Marsh McLennan now?
We won't decide for you. The facts: 42% of analysts rate it a buy, median target $202 (+6%). Weigh that against valuation (P/E ~24). This is not personalized advice.
Is it too late to invest in Marsh McLennan?
Not according to analysts: the median target ($202) is still +6% above the current price ($190). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Marsh McLennan still worth investing in?
It depends on the gap between the price ($190) and its estimated value: analysts target $202 on median (+6%), with 42% buys. Cross-check with their real reliability on MRSH and the cautions above. Information, not advice.
What's the main risk in buying MRSH?
The consensus is not unanimous: of 12 ratings, 6 are neutral and 1 is a sell.
→ Go deeper: the full Marsh McLennan profile (consensus, analyst reliability, price target, performance).